Status: current, Primitive. Date: 31-Jan 2002. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
2154351010 | Sulfafurazole acetyl | en | Synonym | Active | Case insensitive | SNOMED CT core |
2155373010 | Sulfisoxazole acetyl | en | Synonym | Active | Case insensitive | SNOMED CT core |
3485327016 | Sulfafurazole acetyl (substance) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Sulfisoxazole acetyl | Is a | Sulfisoxazole | false | Inferred relationship | Some | ||
Sulfisoxazole acetyl | Is a | Sulfafurazole-containing product | false | Inferred relationship | Some | ||
Sulfisoxazole acetyl | Is a | Sulfonamide antibacterial | true | Inferred relationship | Some | ||
Sulfisoxazole acetyl | Is modification of | Sulfisoxazole | true | Inferred relationship | Some | ||
Sulfisoxazole acetyl | Has disposition | Antibacterial | true | Inferred relationship | Some |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Sulphisoxazole acetyl 500mg/5mL suspension | Has active ingredient | False | Sulfisoxazole acetyl | Inferred relationship | Some | |
Sulphisoxazole acetyl 0.5g/5mL suspension | Has active ingredient | False | Sulfisoxazole acetyl | Inferred relationship | Some | |
Erythromycin ethylsuccinate + sulphisoxazole acetyl 200mg/600mg oral suspension | Has active ingredient | False | Sulfisoxazole acetyl | Inferred relationship | Some | |
Erythromycin ethyl succinate and sulfafurazole acetyl product | Has active ingredient | False | Sulfisoxazole acetyl | Inferred relationship | Some |
Reference Sets
Substance foundation reference set